Repare Therapeutics Stock Price on October 15, 2024
| RPTX Stock | USD 2.81 0.16 5.39% |
Below is the normalized historical share price chart for Repare Therapeutics extending back to June 19, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Repare Therapeutics stands at 2.81, as last reported on the 24th of November, with the highest price reaching 3.09 and the lowest price hitting 2.78 during the day.
If you're considering investing in Repare Stock, it is important to understand the factors that can impact its price. Repare Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.0194, which implies the firm had a -0.0194% return per unit of risk over the last 3 months. Repare Therapeutics exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Repare Therapeutics' Coefficient Of Variation of 40232.04, risk adjusted performance of 0.0102, and Semi Deviation of 3.51 to confirm the risk estimate we provide.
At this time, Repare Therapeutics' Common Stock Total Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 267.7 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 35.7 M in 2024. . At this time, Repare Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 1.52 in 2024, whereas Price To Sales Ratio is likely to drop 5.71 in 2024. Repare Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 19th of June 2020 | 200 Day MA 3.8613 | 50 Day MA 3.3917 | Beta 0.713 |
Repare |
Sharpe Ratio = -0.0194
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RPTX |
Estimated Market Risk
| 4.44 actual daily | 39 61% of assets are more volatile |
Expected Return
| -0.09 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Repare Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Repare Therapeutics by adding Repare Therapeutics to a well-diversified portfolio.
Price Book 0.6828 | Enterprise Value Ebitda 0.5798 | Price Sales 1.7957 | Shares Float 20.2 M | Wall Street Target Price 12.5 |
Related Headline
Nurix Therapeutics Headline on 15th of October 2024
Nurix Therapeutics Given New 26.00 Price Target at Royal Ban... by thelincolnianonline.com
Nurix Therapeutics had its price target decreased by Royal Bank of Canada from 27.00 to 26.00 in a report released on Monday, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the stock. Several other equities analysts have also issued reports on the company. Needham Company LLC
Repare Therapeutics Valuation on October 15, 2024
It is possible to determine the worth of Repare Therapeutics on a given historical date. On October 15, 2024 Repare was worth 3.4 at the beginning of the trading date compared to the closed value of 3.36. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Repare Therapeutics stock. Still, in general, we apply an absolute valuation method to find Repare Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Repare Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Repare Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 3.14 | 3.45 | 3.12 | 3.39 | 87,640 | |
10/15/2024 | 3.40 | 3.44 | 3.30 | 3.36 | 69,301 |
| 3.37 | 3.47 | 3.34 | 3.42 | 53,306 |
| Backtest Repare Therapeutics | | | Repare Therapeutics History | | | Repare Therapeutics Valuation | Previous | Next |
Repare Therapeutics Trading Date Momentum on October 15, 2024
| On October 16 2024 Repare Therapeutics was traded for 3.42 at the closing time. The top price for the day was 3.47 and the lowest listed price was 3.34 . The trading volume for the day was 53.3 K. The trading history from October 16, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 1.79% . The trading delta at closing time against the current closing price is 0.60% . |
Repare Therapeutics Fundamentals Correlations and Trends
By evaluating Repare Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Repare Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Repare financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Repare Therapeutics Stock history
Repare Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Repare is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Repare Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Repare Therapeutics stock prices may prove useful in developing a viable investing in Repare Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 42.1 M | 35.7 M | |
| Net Loss | -26.1 M | -27.4 M |
Repare Therapeutics Quarterly Net Working Capital |
|
Repare Therapeutics Stock Technical Analysis
Repare Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Repare Therapeutics Period Price Range
Low | November 24, 2024
| High |
0.00 | 0.00 |
Repare Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Repare Therapeutics November 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Repare Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Repare Therapeutics shares will generate the highest return on investment. By undertsting and applying Repare Therapeutics stock market strength indicators, traders can identify Repare Therapeutics entry and exit signals to maximize returns
Repare Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Repare Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Repare Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Repare to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0102 | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.70) | |||
| Sortino Ratio | (0.03) | |||
| Treynor Ratio | 0.0011 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Repare Stock Analysis
When running Repare Therapeutics' price analysis, check to measure Repare Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repare Therapeutics is operating at the current time. Most of Repare Therapeutics' value examination focuses on studying past and present price action to predict the probability of Repare Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repare Therapeutics' price. Additionally, you may evaluate how the addition of Repare Therapeutics to your portfolios can decrease your overall portfolio volatility.